Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine.
Keith W PratzBrian A JonasVinod PullarkatChristian RecherAndre C SchuhMichael J ThirmanJacqueline S GarciaCourtney D D DiNardoVladimir VorobyevNicola Stefano FracchiollaSu-Peng YehJun Ho JangMuhit ÖzcanKazuhito YamamotoArpad IllesYing ZhouMonique DailBrenda ChylaJalaja PotluriHartmut DöhnerPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
.